tiprankstipranks
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market
4569
KYORIN Pharmaceutical Co.,Ltd.
RESEARCH TOOLSreports
Want to see JP:4569 full AI Analyst Report?

KYORIN Pharmaceutical Co.,Ltd. (4569) Financial Statements

3 Followers

KYORIN Pharmaceutical Co.,Ltd. Financial Overview

KYORIN Pharmaceutical Co.,Ltd.'s market cap is currently ¥59.43B. The company's EPS TTM is ¥179.3; its P/E ratio is 19.16; and it has a dividend yield of 3.36%. KYORIN Pharmaceutical Co.,Ltd. is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 126.26B¥ 130.09B¥ 119.53B¥ 113.27B¥ 105.53B
Gross Profit¥ 51.61B¥ 59.51B¥ 51.62B¥ 50.16B¥ 49.44B
Operating Income¥ 3.57B¥ 12.55B¥ 6.23B¥ 5.12B¥ 5.00B
EBITDA¥ 8.22B¥ 17.15B¥ 10.52B¥ 8.96B¥ 8.72B
Net Income¥ 3.45B¥ 9.09B¥ 5.47B¥ 4.72B¥ 3.93B
Balance Sheet
Cash & Short-Term Investments¥ 15.08B¥ 16.51B¥ 13.98B¥ 19.39B¥ 27.49B
Total Assets¥ 195.46B¥ 193.62B¥ 177.63B¥ 176.04B¥ 171.92B
Total Debt¥ 23.79B¥ 28.44B¥ 20.95B¥ 21.28B¥ 21.62B
Net Debt¥ 11.98B¥ 13.42B¥ 7.06B¥ 1.88B¥ -5.37B
Total Liabilities¥ 53.02B¥ 57.33B¥ 46.89B¥ 50.58B¥ 47.41B
Stockholders' Equity¥ 142.43B¥ 136.28B¥ 130.74B¥ 125.46B¥ 124.51B
Cash Flow
Free Cash Flow¥ 2.52B¥ -2.19B¥ -4.23B¥ -4.32B¥ 3.90B
Operating Cash Flow¥ 6.38B¥ 3.51B¥ 1.55B¥ 2.01B¥ 6.35B
Investing Cash Flow¥ -1.64B¥ -6.32B¥ -3.19B¥ -6.28B¥ -2.56B
Financing Cash Flow¥ -7.96B¥ 3.95B¥ -3.35B¥ -3.36B¥ -4.11B
Currency in JPY

KYORIN Pharmaceutical Co.,Ltd. Earnings and Revenue History

Income Statement >

KYORIN Pharmaceutical Co.,Ltd. Debt to Assets

Balance Sheet >

KYORIN Pharmaceutical Co.,Ltd. Cash Flow

Cash Flow >

KYORIN Pharmaceutical Co.,Ltd. Forecast EPS vs Actual EPS

Earnings >